论文信息 - Azacitidine combined with the selective FLT3 kinase inhibitor crenolanib disrupts stromal protection and inhibits expansion of residual leukemia-initiating cells in FLT3-ITD AML with concurrent epigenetic mutations - 字舞流文

Azacitidine combined with the selective FLT3 kinase inhibitor crenolanib disrupts stromal protection and inhibits expansion of residual leukemia-initiating cells in FLT3-ITD AML with concurrent epigenetic mutations

K. Döhner | V. Gaidzik | Christoph Ziegenhain | Martha Smets | B. Vick | Anne-Kathrin Garz | K. Götze | I. Jeremias | M. Rudelius | R. Oostendorp | C. Peschel | S. Bultmann | U. Keller | C. Thiede | S. Grath | S. Habringer | S. Herold | Marie‑Theresa Weickert | Saskia Wolf | C. Ziegenhain | Stefan Habringer | Sonja Grath | Sebastian Bultmann